<DOC>
	<DOC>NCT00101738</DOC>
	<brief_summary>The primary objective of the study is to evaluate that 3 immunosuppressant regimens will have comparable kidney function results in kidney transplant patients.</brief_summary>
	<brief_title>Freedom Study: Myfortic in Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Males and females aged 18 to 75 years. Recipients of first, heartbeating cadaveric, living unrelated or living related nonHLA identical donor kidney transplant, treated with Simulect® and Neoral® as primary immunosuppression. Second or subsequent kidney transplant or multiorgan recipients (e.g. kidney and pancreas) or previous transplant with any other organ. Kidneys from nonheart beating donors or HLA identical living related donors. ABO incompatibility against the donor.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>MPA</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Acute rejection</keyword>
	<keyword>Kidney function</keyword>
</DOC>